Sara Lavi

8.4k citations

72 papers · 6.7k indexed · 3 hit papers · h-index 38

Impact in

Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Polyomavirus and related diseases
Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research

Papers in

Oncology 31
- HER2/EGFR in Cancer Research 16
- Polyomavirus and related diseases 12
Cancer Research 12

Co-authors: Yosef Yarden Gil Levkowitz Hadassa Waterman Barry Ratzkin Devarajan Karunagaran Eldad Tzahar Michael Sela Iris Alroy
Journals: Molecular and Cellular Biology (10 papers)Proceedings of the National Academy of Sciences (9 papers)Journal of Biological Chemistry (8 papers)Oncogene (6 papers)Virology (5 papers)
Partner nations: Israel United States Germany

In The Last Decade

Sara Lavi

72 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

Ubiquitin Ligase Activity and Tyrosine Phosphorylation Underlie Suppression of Growth Factor Signaling by c-Cbl/Sli-1 1999 · 823 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1999 Molecular Cell
1996 Molecular and Cellular Biology
1996 The EMBO Journal

Peers

Countries citing papers authored by Sara Lavi

Since Specialization

Citations

This map shows the geographic impact of Sara Lavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Lavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Lavi more than expected).

Fields of papers citing papers by Sara Lavi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Lavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Lavi. The network helps show where Sara Lavi may publish in the future.

Co-authors

The 25 scholars most cited alongside Sara Lavi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sara Lavi Line = papers co-authored together Sara Lavi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Examination of HER3 targeting in cancer using monoclonal antibodies Proceedings of the National Academy of Sciences ·Nadège Gaborit, Ali Abdul‐Hai, Maicol Mancini, Moshit Lindzen, Sara Lavi, Orith Leitner, Stéphanie Desgouilles, Valéria Nancí de Macêdo Santana, Dai Jin-feng, Hongjian Xu, Christel Larbouret, Thierry Chardès, Hervé Bazin, André Pèlegrin, Michael Sela, Yosef Yarden	2015	35
2	Protein Phosphatase Magnesium Dependent 1A Governs the Wound Healing–Inflammation–Angiogenesis Cross Talk on Injury American Journal Of Pathology ·Stefano Caldoro, Hadas Sar Shalom, M. Shohat, Daniella Ben‐Meir, Shiran Ferber, Ronit Satchi‐Fainaro, Ruth Ashery‐Padan, Mordechai Rosner, A Solomon, Sara Lavi	2014	23
3	Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR Proceedings of the National Academy of Sciences ·Daniela A. Ferraro, Nadège Gaborit, Ruth Maron, Hadas Cohen‐Dvashi, Ziv Porat, Fresia Pareja, Sara Lavi, Moshit Lindzen, Nir Ben‐Chetrit, Michael Sela, Yosef Yarden	2013	93
4	De novo synthesis of protein phosphatase 1A, magnesium dependent, alpha isoform (PPM1A) during oocyte maturation Cellular & Molecular Biology Letters ·Dana Chuderland, Stefano Caldoro, Z. Chen, Daniella Ben‐Meir, Ruth Shalgi, Sara Lavi	2012	8
5	A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis Oncogene ·Moshit Lindzen, Sílvia Carvalho, Alex Starr, Nir Ben‐Chetrit, Yahya Saputra, Wolfgang J. Köstler, A. Rabinkov, Sara Lavi, Sarah Bacus, Yosef Yarden	2011	25
6	Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression Oncogene ·Fresia Pareja, Daniela A. Ferraro, Aldo Caprini, Hadas Cohen‐Dvashi, Luciana Nogueira dos Santos, Sebastian Aulmann, Nir Ben‐Chetrit, Gur Pines, И.Ғ. Икрамов, Nicola Crosetto, Wolfgang J. Köstler, Sílvia Carvalho, Sara Lavi, Fernando Schmitt, (unknown), Zohar Yakhini, Hans‐Peter Sinn, G.B. Mills, Y Yarden	2011	82
7	Role of Type 2C Protein Phosphatases in Growth Regulation and in Cellular Stress Signaling Critical Reviews in Biochemistry and Molecular Biology ·Twan Lammers, Sara Lavi	2007	132
8	Mouse major satellite DNA is prone to eccDNA formation via DNA Ligase IV-dependent pathway Oncogene ·Rozmie Razif Othaman, Eran Bacharach, Sara Lavi	2006	48
9	Conjugation to Nedd8 Instigates Ubiquitylation and Down-regulation of Activated Receptor Tyrosine Kinases Journal of Biological Chemistry ·Shlomo Oved, Yaron Mosesson, Yaara Zwang, Elena Santonico, Keren Shtiegman, Mina D. Marmor, Bose Kochupurakkal, Menachem Katz, Sara Lavi, Gianni Cesareni, Yosef Yarden	2006	136
10	Epigen, the Last Ligand of ErbB Receptors, Reveals Intricate Relationships between Affinity and Mitogenicity Journal of Biological Chemistry ·Bose Kochupurakkal, Daniel Harari, Yosephine Angelia Hutapea, Galia Maik-Rachline, Ljuba Lyass, Gal Gur, Oluwashanu Balogun, Ami Citri, Sara Lavi, Raya Eilam, Vered Chalifa‐Caspi, Zelig Eshhar, Eli Pikarsky, Ronit Pinkas‐Kramarski, Sarah Bacus, Yosef Yarden	2004	76
11	Polar Expression of ErbB-2/HER2 in Epithelia Developmental Cell ·Maya Shelly, Yaron Mosesson, Ami Citri, Sara Lavi, Yaara Zwang, Naomi Melamed‐Book, Benjamin Aroeti, Yosef Yarden	2003	51
12	An Inducible System to Study the Growth Arrest Properties of Protein Phosphatase 2C Methods in enzymology on CD-ROM/Methods in enzymology ·Paula Ofek, Daniella Ben‐Meir, Sara Lavi	2003	2
13	Cell Cycle Regulation and p53 Activation by Protein Phosphatase 2Cα Journal of Biological Chemistry ·Paula Ofek, Daniella Ben‐Meir, Zehavit Kariv-Inbal, Moshe Oren, Sara Lavi	2003	69
14	c-Cbl Is a Suppressor of the Neu Oncogene Journal of Biological Chemistry ·Gil Levkowitz, Shlomo Oved, Leah N. Klapper, Daniel Harari, Sara Lavi, Michael Sela, Yosef Yarden	2000	65
15	Ubiquitin Ligase Activity and Tyrosine Phosphorylation Underlie Suppression of Growth Factor Signaling by c-Cbl/Sli-1 Molecular Cell ·Gil Levkowitz, Hadassa Waterman, Seth A. Ettenberg, Menachem Katz, Alexander Y. Tsygankov, Iris Alroy, Sara Lavi, Kazuhiro Iwaï, Yuval Reiss, Aaron Ciechanover, Stanley Lipkowitz, Yosef Yarden Hit paper breakdown →	1999	823
16	ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network Molecular and Cellular Biology ·Ronit Pinkas‐Kramarski, Maya Shelly, A. Siedow, Sarah Omberg, Ljuba Lyass, Iris Alroy, Mahmoud Mohammed mahmoud Nasef, Angera H. Kuo, James D. Moyer, Sara Lavi, Miriam Eisenstein, Barry Ratzkin, Rony Seger, Sarah Bacus, Jacalyn H. Pierce, Glenn C. Andrews, Yosef Yarden	1998	113
17	Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. The EMBO Journal ·Ronit Pinkas‐Kramarski, Lior Soussan, Hayley R. Waterman, Gil Levkowitz, Iris Alroy, Leah N. Klapper, Sara Lavi, Rony Seger, Barry Ratzkin, Michael Sela, Yosef Yarden Hit paper breakdown →	1996	645
18	ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. Journal of Biological Chemistry ·Eldad Tzahar, Gil Levkowitz, Devarajan Karunagaran, Ling Yi, Elior Peles, Sara Lavi, David Chang, Spittle Mf, C. Rosa, D Wen	1994	234
19	The mechanism of carcinogen-induced DNA amplification: in vivo and in vitro studies Mutation Research/Reviews in Genetic Toxicology ·Mirit I. Aladjem, Sara Lavi	1992	11
20	Carcinogen-Induced DNA Amplification In Vitro: Overreplication of the Simian Virus 40 Origin Region in Extracts from Carcinogen-Treated CO60 Cells Molecular and Cellular Biology ·Nianming Xia, Maité Ochoa, David Hassin, Sara Lavi	1990	1

About Sara Lavi

Sara Lavi is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 72 papers that have together received 6.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Polyomavirus and related diseases (12 papers), Bacteriophages and microbial interactions (10 papers), Glycosylation and Glycoproteins Research (9 papers), Ubiquitin and proteasome pathways (9 papers), CRISPR and Genetic Engineering (8 papers) and DNA Repair Mechanisms (7 papers). The work is most often cited by research in Oncology (3.2k citations), Radiology, Nuclear Medicine and Imaging (1.6k citations), Molecular Biology (4.4k citations), Immunology and Allergy (345 citations) and Cancer Research (783 citations). Sara Lavi has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Yosef Yarden, Gil Levkowitz, Hadassa Waterman, Barry Ratzkin, Devarajan Karunagaran, Eldad Tzahar, Michael Sela, Iris Alroy, Aaron J. Shatkin and Ernest Winocour. Their work appears in journals such as Molecular and Cellular Biology, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Oncogene and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact